The largest community of pharma leaders

Cognito Therapeutics Announces Appointment of Dr. Mihály Hajós as Chief Scientific Officer

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cognito Therapeutics announced today that Dr. Mihály Hajós, has been appointed Chief Scientific Officer. http://www.businesswire.com/news/home/20190626005229/en/Cognito-Therapeutics-Announces-Appointment-Dr.-Mih%C3%A1ly-Haj%C3%B3s/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==

Recent Articles

TAGRISSO Reduced the Risk of Disease Recurrence in the Brain by 82% in the Adjuvant Treatment of Early-Stage EGFR-Mutated Lung Cancer

WILMINGTON, Del.--(BUSINESS WIRE)--Results from a prespecified exploratory analysis of the positive...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.